Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This Phase 1b will describe the safety and immunogenicity of 2 multivalent pneumococcal conjugate vaccine formulations in healthy Japanese adults in the United States.
Epistemonikos ID: 7da9a6bca60ec302e0729a2973bf63b93e15ff64
First added on: May 21, 2024